Source: Annual Congress 2010 - Respiratory system involvement in non-pulmonary disorders
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M. Szmidt, M. Malinowska (Zgierz, Poland). Usefulness of procalcitonin as a marker of bacterial inflammation in patients with heart failure and suspected pneumonia in x-ray examination. Eur Respir J 2010; 36: Suppl. 54, 5430

Member's Comments

No comment yet.

Related content which might interest you: The clinical significance of serum and bronchoalveoalr lavage inflammatory cytokine in patients with acute respiratory failure due to severe community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 347s Year: 2006 Value of serum procalcitonin levels in the differential diagnosis of pneumonia and pulmonary embolism Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia Year: 2011 The diagnostic value of serum procalcitonin in differential diagnosis of pulmonary embolism and pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 462s Year: 2007 Utility of chest echography and pulmonary infection score in early diagnosis of ventilator associated pneumonia Source: International Congress 2018 – Imaging of various diseases with different imaging modalities Year: 2018 Usefulness of bronchoscopy in acute interstitial lung diseases Source: International Congress 2018 – PG6 Bronchoscopy in pulmonary emergencies Year: 2018 Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD) Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy Source: Eur Respir J, 54 (1) 1802442; 10.1183/13993003.02442-2018 Year: 2019 Diagnostic utility of serum KL-6 levels in acute respiratory failure with bilateral pulmonary infiltrates Source: Virtual Congress 2020 – Experimental and laboratory studies in intensive care unit medicine Year: 2020 Evaluation of lung biopsy techniques for diagnosis of idiopathic interstitial pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 597s Year: 2006 Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia Source: Eur Respir J 2008; 32: 726-732 Year: 2008 Copeptin – a marker for differential diagnosis between acute exacerbation of COPD and heart failure in patients with acute dyspnea Source: Virtual Congress 2021 – Biomarkers for the management of bronchial obstructive diseases Year: 2021 Usefulness of shock index in severity assessment of community-acquired pneumonia Source: Annual Congress 2007 - Miscellaneous lower respiratory tract infections Year: 2007 Procalcitonin as etiological marker of severe community-acquired pneumonia Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 Usefulness of C-reactive protein and procalcitonin in predicting mortality in community-acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016 The role of procalcitonin (PCT) in differential diagnosis of pneumonia and pulmonary congestion associated with end-stage renal failure (ESRF) Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD Year: 2008 Lung biopsy in patients with suspected idiopathic pulmonary fibrosis and probable interstitial pneumonia on the CT scan. Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019 Role of chest ultrasonography in prognosis of community-acquired pneumonia Source: International Congress 2016 – A view into a chest and pleural pathology Year: 2016 Usefulness of GDF-15 as a biomarker of respiratory worsening in COVID-19 patients. Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021